The Nigerian unit of British drugmaker GlaxoSmithKline on Tuesday reported 2013 pretax profit up 3.4 percent to 4.31 billion naira ($26 million), from 4.17 billion naira the previous year.
Turnover grew 15.3 percent to 29.18 billion naira during the period, compared with 25.31 billion naira a year earlier, the company said in a filing with the Nigerian Stock Exchange.
Reuters

